Serveur d'exploration H2N2

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Extended antigen sparing potential of AS03-adjuvanted pandemic H1N1 vaccines in children, and immunological equivalence of two formulations of AS03-adjuvanted H1N1 vaccines: results from two randomised trials.

Identifieur interne : 000780 ( Main/Exploration ); précédent : 000779; suivant : 000781

Extended antigen sparing potential of AS03-adjuvanted pandemic H1N1 vaccines in children, and immunological equivalence of two formulations of AS03-adjuvanted H1N1 vaccines: results from two randomised trials.

Auteurs : Odile Launay [France] ; Xavier Duval [France] ; Serge Fitoussi [France] ; Wolfgang Jilg [Allemagne] ; Angkool Kerdpanich [Thaïlande] ; May Montellano [Philippines] ; Tino Schwarz [Allemagne] ; Veerachai Watanveerade [Thaïlande] ; Jürgen Wenzel [Allemagne] ; Gerard Zalcman [France] ; Vinod Bambure [Inde] ; Ping Li [États-Unis] ; Adrian Caplanusi [Belgique] ; Anuradha Madan [États-Unis] ; Paul Gillard [Belgique] ; David Vaughn [États-Unis]

Source :

RBID : Hal:inserm-00868824

English descriptors

Abstract

BACKGROUND: Pandemicinfluenza vaccinemanufacturing capacity and distribution agility is enhanced through the availabilityof equivalent antigen-sparing vaccines. We evaluated equivalence in terms of immunogenicity between GlaxoSmithKline Vaccines' A/California/7/2009(H1N1)v-like-AS03 vaccines manufactured in Dresden (D-Pan), and Quebec (Q-Pan). METHODS: In two studies,334 adults 18-60 years of age received 2 doses of D-Pan or Q-Pan containing 3.75 mug haemagglutinin antigen (HA) adjuvanted with AS03Aadministered21 days apart, and 209 children 3-9 years of age received 1reduced dose of D-Panor Q-Pan (0.9 mug HA) or Q-Pan (1.9 mug HA) with AS03B. Haemagglutination inhibition (HI)titres were assessed before and 21 days post-vaccination. HI persistence was assessed after 12 months in adults and 6 months in children. RESULTS: Pre-defined criteria for immunological equivalence of Q-Pan versus D-Pan were achieved in both populations. After one vaccine dose, >=97.6% of adults and children had HI titres >=1:40, with increases in titre>=25.7-fold. CHMP and CBER regulatory acceptance criteria for influenza vaccines were exceeded by all groups in both studies at Day 21. In adults,the percentage with HI titres >=1:40 at Month 12 was 82.9% (Q-Pan) and 84.0% (D-Pan). In children, the percentages at Month 6 were 75.3.3% (Q-Pan0.9), 85.1% (D-Pan0.9) and 79.3% (Q-Pan1.9). Safety profile of the study vaccines was consistent with previously published data. CONCLUSION: Two studies indicate that A/California/7/2009 (H1N1)v-like HA manufactured at two sitesand combined with AS03 are equivalent in terms of immunogenicity in adults and children and highly immunogenic. Different HA doses elicited an adequate immune response through 180 days post-vaccination in children 3-9 years of age.Trial registrationClinicalTrials.gov: NCT00979407 and NCT01161160.


Url:
DOI: 10.1186/1471-2334-13-435


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Extended antigen sparing potential of AS03-adjuvanted pandemic H1N1 vaccines in children, and immunological equivalence of two formulations of AS03-adjuvanted H1N1 vaccines: results from two randomised trials.</title>
<author>
<name sortKey="Launay, Odile" sort="Launay, Odile" uniqKey="Launay O" first="Odile" last="Launay">Odile Launay</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-232778" status="INCOMING">
<orgName>REseau national d'Investigation clinique en VACcinologie</orgName>
<orgName type="acronym">REIVAC</orgName>
<desc>
<address>
<addrLine>Bâtiment Lavoisier - 27, rue du Faubourg Saint Jacques - 75014 PARIS</addrLine>
<country key="FR"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-356457" type="direct"></relation>
<relation active="#struct-303623" type="direct"></relation>
<relation active="#struct-302361" type="direct"></relation>
<relation active="#struct-300142" type="direct"></relation>
<relation active="#struct-300123" type="direct"></relation>
<relation active="#struct-300068" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-356457" type="direct">
<org type="institution" xml:id="struct-356457" status="INCOMING">
<orgName>Centre National de Gestion des Essais de Produits de Santé (CeNGEPS)</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
<tutelle active="#struct-303623" type="direct">
<org type="institution" xml:id="struct-303623" status="VALID">
<idno type="IdRef">026388278</idno>
<orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
<orgName type="acronym">INSERM</orgName>
<desc>
<address>
<addrLine>101, rue de Tolbiac, 75013 Paris </addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.inserm.fr</ref>
</desc>
</org>
</tutelle>
<tutelle active="#struct-302361" type="direct">
<org type="institution" xml:id="struct-302361" status="VALID">
<orgName>Groupe hospitalier Broca</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
<tutelle active="#struct-300142" type="direct">
<org type="institution" xml:id="struct-300142" status="VALID">
<orgName>Hôtel-Dieu</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
<tutelle active="#struct-300123" type="direct">
<org type="institution" xml:id="struct-300123" status="VALID">
<orgName>CHU Cochin [AP-HP]</orgName>
<desc>
<address>
<addrLine>27 Rue du Faubourg Saint-Jacques 75014 Paris</addrLine>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
<tutelle active="#struct-300068" type="direct">
<org type="regroupinstitution" xml:id="struct-300068" status="VALID">
<orgName>Assistance publique - Hôpitaux de Paris (AP-HP)</orgName>
<orgName type="acronym">APHP</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Duval, Xavier" sort="Duval, Xavier" uniqKey="Duval X" first="Xavier" last="Duval">Xavier Duval</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-2607" status="VALID">
<orgName>CIC - CHU Bichat</orgName>
<desc>
<address>
<addrLine>Gh Xavier Bichat - Claude Bernard PARIS VII 46, Rue Henri Huchard 75018 PARIS</addrLine>
<country key="FR"></country>
</address>
</desc>
<listRelation>
<relation name="CIC7" active="#struct-303623" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle name="CIC7" active="#struct-303623" type="direct">
<org type="institution" xml:id="struct-303623" status="VALID">
<idno type="IdRef">026388278</idno>
<orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
<orgName type="acronym">INSERM</orgName>
<desc>
<address>
<addrLine>101, rue de Tolbiac, 75013 Paris </addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.inserm.fr</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Fitoussi, Serge" sort="Fitoussi, Serge" uniqKey="Fitoussi S" first="Serge" last="Fitoussi">Serge Fitoussi</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-232781" status="INCOMING">
<orgName>Essais Cliniques de Phase 1 à 2A</orgName>
<desc>
<address>
<addrLine>6 avenue Mozart 86000 Poitiers</addrLine>
<country key="FR"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-356458" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-356458" type="direct">
<org type="institution" xml:id="struct-356458" status="INCOMING">
<orgName>Mediscis : Medical Science Services</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Jilg, Wolfgang" sort="Jilg, Wolfgang" uniqKey="Jilg W" first="Wolfgang" last="Jilg">Wolfgang Jilg</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-232782" status="VALID">
<orgName>Institute of Medical Microbiology and Hygiene</orgName>
<orgName type="acronym">IMHR</orgName>
<desc>
<address>
<addrLine>Universitätsstraße 31, 93053 Regensburg</addrLine>
<country key="DE"></country>
</address>
<ref type="url">https://www.imhr.de/en/</ref>
</desc>
<listRelation>
<relation active="#struct-303027" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-303027" type="direct">
<org type="institution" xml:id="struct-303027" status="VALID">
<orgName>Universität Regensburg</orgName>
<orgName type="acronym">UR</orgName>
<date type="start">2016-10-17</date>
<desc>
<address>
<addrLine>Universitätsstraße 31, 93053 Regensburg</addrLine>
<country key="DE"></country>
</address>
<ref type="url">http://www.uni-regensburg.de</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Allemagne</country>
</affiliation>
</author>
<author>
<name sortKey="Kerdpanich, Angkool" sort="Kerdpanich, Angkool" uniqKey="Kerdpanich A" first="Angkool" last="Kerdpanich">Angkool Kerdpanich</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-232783" status="INCOMING">
<orgName>Infectious Diseases Unit</orgName>
<desc>
<address>
<addrLine>Department of Pediatrics, 315 Ratchvidhi Rd. Thung Phyathai, Ratchthewi Bangkok 10400</addrLine>
<country key="TH"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-356459" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-356459" type="direct">
<org type="institution" xml:id="struct-356459" status="INCOMING">
<orgName>Phramongkutklao Hospital, Bangkok</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Thaïlande</country>
</affiliation>
</author>
<author>
<name sortKey="Montellano, May" sort="Montellano, May" uniqKey="Montellano M" first="May" last="Montellano">May Montellano</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-232784" status="INCOMING">
<orgName>Department of Pediatrics</orgName>
<desc>
<address>
<addrLine>667 Gastambide St.,Sampaloc, Manila</addrLine>
<country key="PH"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-356261" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-356261" type="direct">
<org type="institution" xml:id="struct-356261" status="INCOMING">
<orgName>Mary Chiles General Hospital</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Philippines</country>
</affiliation>
</author>
<author>
<name sortKey="Schwarz, Tino" sort="Schwarz, Tino" uniqKey="Schwarz T" first="Tino" last="Schwarz">Tino Schwarz</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-232785" status="INCOMING">
<orgName>Central Laboratory and Vaccination Centre</orgName>
<desc>
<address>
<addrLine>Klinikstrasse 1 - D 97070 Würzburg</addrLine>
<country key="DE"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-356262" type="direct"></relation>
<relation active="#struct-356460" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-356262" type="direct">
<org type="institution" xml:id="struct-356262" status="INCOMING">
<orgName>StiftungJuliusspital</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
<tutelle active="#struct-356460" type="direct">
<org type="institution" xml:id="struct-356460" status="INCOMING">
<orgName>StiftungJuliusspital Würzburg</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Allemagne</country>
</affiliation>
</author>
<author>
<name sortKey="Watanveerade, Veerachai" sort="Watanveerade, Veerachai" uniqKey="Watanveerade V" first="Veerachai" last="Watanveerade">Veerachai Watanveerade</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-232783" status="INCOMING">
<orgName>Infectious Diseases Unit</orgName>
<desc>
<address>
<addrLine>Department of Pediatrics, 315 Ratchvidhi Rd. Thung Phyathai, Ratchthewi Bangkok 10400</addrLine>
<country key="TH"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-356459" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-356459" type="direct">
<org type="institution" xml:id="struct-356459" status="INCOMING">
<orgName>Phramongkutklao Hospital, Bangkok</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Thaïlande</country>
</affiliation>
</author>
<author>
<name sortKey="Wenzel, Jurgen" sort="Wenzel, Jurgen" uniqKey="Wenzel J" first="Jürgen" last="Wenzel">Jürgen Wenzel</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-232782" status="VALID">
<orgName>Institute of Medical Microbiology and Hygiene</orgName>
<orgName type="acronym">IMHR</orgName>
<desc>
<address>
<addrLine>Universitätsstraße 31, 93053 Regensburg</addrLine>
<country key="DE"></country>
</address>
<ref type="url">https://www.imhr.de/en/</ref>
</desc>
<listRelation>
<relation active="#struct-303027" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-303027" type="direct">
<org type="institution" xml:id="struct-303027" status="VALID">
<orgName>Universität Regensburg</orgName>
<orgName type="acronym">UR</orgName>
<date type="start">2016-10-17</date>
<desc>
<address>
<addrLine>Universitätsstraße 31, 93053 Regensburg</addrLine>
<country key="DE"></country>
</address>
<ref type="url">http://www.uni-regensburg.de</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Allemagne</country>
</affiliation>
</author>
<author>
<name sortKey="Zalcman, Gerard" sort="Zalcman, Gerard" uniqKey="Zalcman G" first="Gerard" last="Zalcman">Gerard Zalcman</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-149166" status="VALID">
<orgName>Centre de recherche clinique [CHU Caen]</orgName>
<orgName type="acronym">CRC</orgName>
<desc>
<address>
<addrLine>Centre Hospitalier UniversitaireAvenue de la Côte de NacreCS 3000114033 CAEN cedex 9</addrLine>
<country key="FR"></country>
</address>
<ref type="url">https://www.chu-caen.fr/crcbn.html</ref>
</desc>
<listRelation>
<relation active="#struct-7127" type="direct"></relation>
<relation active="#struct-455934" type="indirect"></relation>
<relation active="#struct-300185" type="direct"></relation>
<relation active="#struct-575575" type="indirect"></relation>
<relation active="#struct-301261" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-7127" type="direct">
<org type="institution" xml:id="struct-7127" status="VALID">
<idno type="IdRef">026403064</idno>
<idno type="ISNI">0000000121864076</idno>
<orgName>Université de Caen Normandie</orgName>
<orgName type="acronym">UNICAEN</orgName>
<date type="start">1432-01-01</date>
<desc>
<address>
<addrLine>Esplanade de la Paix - CS 14032 - 14032 CAEN Cedex 5</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.unicaen.fr/</ref>
</desc>
<listRelation>
<relation active="#struct-455934" type="direct"></relation>
</listRelation>
</org>
</tutelle>
<tutelle active="#struct-455934" type="indirect">
<org type="regroupinstitution" xml:id="struct-455934" status="VALID">
<idno type="IdRef">190906332</idno>
<idno type="ISNI">0000000417859671 </idno>
<orgName>Normandie Université</orgName>
<orgName type="acronym">NU</orgName>
<date type="start">2015-01-01</date>
<desc>
<address>
<addrLine>Esplanade de la Paix - CS 14032 - 14032 Caen Cedex 5</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.normandie-univ.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle active="#struct-300185" type="direct">
<org type="institution" xml:id="struct-300185" status="VALID">
<idno type="IdRef">031245382</idno>
<orgName>CHU Caen</orgName>
<desc>
<address>
<addrLine>Avenue de la Côte de Nacre 14000 Caen</addrLine>
<country key="FR"></country>
</address>
<ref type="url">https://www.chu-caen.fr/</ref>
</desc>
<listRelation>
<relation active="#struct-455934" type="direct"></relation>
<relation active="#struct-575575" type="direct"></relation>
</listRelation>
</org>
</tutelle>
<tutelle active="#struct-575575" type="indirect">
<org type="regroupinstitution" xml:id="struct-575575" status="VALID">
<orgName>Tumorothèque de Caen Basse-Normandie</orgName>
<orgName type="acronym">TCBN</orgName>
<desc>
<address>
<addrLine>3 avenue du Général Harris14076 Caen cedex 5</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.tumorotheque-caen-basse-normandie.org/</ref>
</desc>
</org>
</tutelle>
<tutelle active="#struct-301261" type="direct">
<org type="institution" xml:id="struct-301261" status="VALID">
<idno type="ISNI">0000 0001 2106 7843 </idno>
<idno type="IdRef">031239218</idno>
<orgName>Centre Régional de Lutte contre le Cancer François Baclesse </orgName>
<orgName type="acronym">CRLC François Baclesse </orgName>
<desc>
<address>
<addrLine>3 avenue général Harris14000 Caen</addrLine>
<country key="FR"></country>
</address>
<ref type="url">https://www.baclesse.fr/</ref>
</desc>
<listRelation>
<relation active="#struct-455934" type="direct"></relation>
<relation active="#struct-575575" type="direct"></relation>
</listRelation>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Bambure, Vinod" sort="Bambure, Vinod" uniqKey="Bambure V" first="Vinod" last="Bambure">Vinod Bambure</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-232788" status="INCOMING">
<orgName>GlaxoSmithKline Vaccines [Bangalore]</orgName>
<desc>
<address>
<addrLine>Bangalore</addrLine>
<country key="IN"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-356461" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-356461" type="direct">
<org type="institution" xml:id="struct-356461" status="INCOMING">
<orgName>India GlaxoSmithKline Pharmaceuticals Ltd. (GSK Rx India)</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Inde</country>
</affiliation>
</author>
<author>
<name sortKey="Li, Ping" sort="Li, Ping" uniqKey="Li P" first="Ping" last="Li">Ping Li</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-232789" status="INCOMING">
<orgName>GlaxoSmithKline Vaccines [King of Prussia]</orgName>
<desc>
<address>
<addrLine>North America (NA) Head, Regulatory Affairs - Vaccines - King of Prussia, PA</addrLine>
<country key="US"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-356462" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-356462" type="direct">
<org type="institution" xml:id="struct-356462" status="VALID">
<orgName>GlaxoSmithKline [King of Prussia]</orgName>
<orgName type="acronym">GSK</orgName>
<desc>
<address>
<addrLine>King of Prussia, PA,</addrLine>
<country key="US"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>États-Unis</country>
</affiliation>
</author>
<author>
<name sortKey="Caplanusi, Adrian" sort="Caplanusi, Adrian" uniqKey="Caplanusi A" first="Adrian" last="Caplanusi">Adrian Caplanusi</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-232790" status="INCOMING">
<orgName>GlaxoSmithKline Vaccines [Wavre]</orgName>
<desc>
<address>
<addrLine>Parc de la Noire Epine Rue Fleming, 20 1300 - Wavre</addrLine>
<country key="BE"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-356463" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-356463" type="direct">
<org type="institution" xml:id="struct-356463" status="INCOMING">
<orgName>GlaxoSmithKline - Site de Wavre-Nord</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Belgique</country>
</affiliation>
</author>
<author>
<name sortKey="Madan, Anuradha" sort="Madan, Anuradha" uniqKey="Madan A" first="Anuradha" last="Madan">Anuradha Madan</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-232789" status="INCOMING">
<orgName>GlaxoSmithKline Vaccines [King of Prussia]</orgName>
<desc>
<address>
<addrLine>North America (NA) Head, Regulatory Affairs - Vaccines - King of Prussia, PA</addrLine>
<country key="US"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-356462" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-356462" type="direct">
<org type="institution" xml:id="struct-356462" status="VALID">
<orgName>GlaxoSmithKline [King of Prussia]</orgName>
<orgName type="acronym">GSK</orgName>
<desc>
<address>
<addrLine>King of Prussia, PA,</addrLine>
<country key="US"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>États-Unis</country>
</affiliation>
</author>
<author>
<name sortKey="Gillard, Paul" sort="Gillard, Paul" uniqKey="Gillard P" first="Paul" last="Gillard">Paul Gillard</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-232790" status="INCOMING">
<orgName>GlaxoSmithKline Vaccines [Wavre]</orgName>
<desc>
<address>
<addrLine>Parc de la Noire Epine Rue Fleming, 20 1300 - Wavre</addrLine>
<country key="BE"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-356463" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-356463" type="direct">
<org type="institution" xml:id="struct-356463" status="INCOMING">
<orgName>GlaxoSmithKline - Site de Wavre-Nord</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Belgique</country>
</affiliation>
</author>
<author>
<name sortKey="Vaughn, David" sort="Vaughn, David" uniqKey="Vaughn D" first="David" last="Vaughn">David Vaughn</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-232789" status="INCOMING">
<orgName>GlaxoSmithKline Vaccines [King of Prussia]</orgName>
<desc>
<address>
<addrLine>North America (NA) Head, Regulatory Affairs - Vaccines - King of Prussia, PA</addrLine>
<country key="US"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-356462" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-356462" type="direct">
<org type="institution" xml:id="struct-356462" status="VALID">
<orgName>GlaxoSmithKline [King of Prussia]</orgName>
<orgName type="acronym">GSK</orgName>
<desc>
<address>
<addrLine>King of Prussia, PA,</addrLine>
<country key="US"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>États-Unis</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">HAL</idno>
<idno type="RBID">Hal:inserm-00868824</idno>
<idno type="halId">inserm-00868824</idno>
<idno type="halUri">https://www.hal.inserm.fr/inserm-00868824</idno>
<idno type="url">https://www.hal.inserm.fr/inserm-00868824</idno>
<idno type="doi">10.1186/1471-2334-13-435</idno>
<date when="2013-09-16">2013-09-16</date>
<idno type="wicri:Area/Hal/Corpus">000098</idno>
<idno type="wicri:Area/Hal/Curation">000098</idno>
<idno type="wicri:Area/Hal/Checkpoint">000153</idno>
<idno type="wicri:explorRef" wicri:stream="Hal" wicri:step="Checkpoint">000153</idno>
<idno type="wicri:doubleKey">1471-2334:2013:Launay O:extended:antigen:sparing</idno>
<idno type="wicri:Area/Main/Merge">000781</idno>
<idno type="wicri:Area/Main/Curation">000780</idno>
<idno type="wicri:Area/Main/Exploration">000780</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Extended antigen sparing potential of AS03-adjuvanted pandemic H1N1 vaccines in children, and immunological equivalence of two formulations of AS03-adjuvanted H1N1 vaccines: results from two randomised trials.</title>
<author>
<name sortKey="Launay, Odile" sort="Launay, Odile" uniqKey="Launay O" first="Odile" last="Launay">Odile Launay</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-232778" status="INCOMING">
<orgName>REseau national d'Investigation clinique en VACcinologie</orgName>
<orgName type="acronym">REIVAC</orgName>
<desc>
<address>
<addrLine>Bâtiment Lavoisier - 27, rue du Faubourg Saint Jacques - 75014 PARIS</addrLine>
<country key="FR"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-356457" type="direct"></relation>
<relation active="#struct-303623" type="direct"></relation>
<relation active="#struct-302361" type="direct"></relation>
<relation active="#struct-300142" type="direct"></relation>
<relation active="#struct-300123" type="direct"></relation>
<relation active="#struct-300068" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-356457" type="direct">
<org type="institution" xml:id="struct-356457" status="INCOMING">
<orgName>Centre National de Gestion des Essais de Produits de Santé (CeNGEPS)</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
<tutelle active="#struct-303623" type="direct">
<org type="institution" xml:id="struct-303623" status="VALID">
<idno type="IdRef">026388278</idno>
<orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
<orgName type="acronym">INSERM</orgName>
<desc>
<address>
<addrLine>101, rue de Tolbiac, 75013 Paris </addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.inserm.fr</ref>
</desc>
</org>
</tutelle>
<tutelle active="#struct-302361" type="direct">
<org type="institution" xml:id="struct-302361" status="VALID">
<orgName>Groupe hospitalier Broca</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
<tutelle active="#struct-300142" type="direct">
<org type="institution" xml:id="struct-300142" status="VALID">
<orgName>Hôtel-Dieu</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
<tutelle active="#struct-300123" type="direct">
<org type="institution" xml:id="struct-300123" status="VALID">
<orgName>CHU Cochin [AP-HP]</orgName>
<desc>
<address>
<addrLine>27 Rue du Faubourg Saint-Jacques 75014 Paris</addrLine>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
<tutelle active="#struct-300068" type="direct">
<org type="regroupinstitution" xml:id="struct-300068" status="VALID">
<orgName>Assistance publique - Hôpitaux de Paris (AP-HP)</orgName>
<orgName type="acronym">APHP</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Duval, Xavier" sort="Duval, Xavier" uniqKey="Duval X" first="Xavier" last="Duval">Xavier Duval</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-2607" status="VALID">
<orgName>CIC - CHU Bichat</orgName>
<desc>
<address>
<addrLine>Gh Xavier Bichat - Claude Bernard PARIS VII 46, Rue Henri Huchard 75018 PARIS</addrLine>
<country key="FR"></country>
</address>
</desc>
<listRelation>
<relation name="CIC7" active="#struct-303623" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle name="CIC7" active="#struct-303623" type="direct">
<org type="institution" xml:id="struct-303623" status="VALID">
<idno type="IdRef">026388278</idno>
<orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
<orgName type="acronym">INSERM</orgName>
<desc>
<address>
<addrLine>101, rue de Tolbiac, 75013 Paris </addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.inserm.fr</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Fitoussi, Serge" sort="Fitoussi, Serge" uniqKey="Fitoussi S" first="Serge" last="Fitoussi">Serge Fitoussi</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-232781" status="INCOMING">
<orgName>Essais Cliniques de Phase 1 à 2A</orgName>
<desc>
<address>
<addrLine>6 avenue Mozart 86000 Poitiers</addrLine>
<country key="FR"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-356458" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-356458" type="direct">
<org type="institution" xml:id="struct-356458" status="INCOMING">
<orgName>Mediscis : Medical Science Services</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Jilg, Wolfgang" sort="Jilg, Wolfgang" uniqKey="Jilg W" first="Wolfgang" last="Jilg">Wolfgang Jilg</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-232782" status="VALID">
<orgName>Institute of Medical Microbiology and Hygiene</orgName>
<orgName type="acronym">IMHR</orgName>
<desc>
<address>
<addrLine>Universitätsstraße 31, 93053 Regensburg</addrLine>
<country key="DE"></country>
</address>
<ref type="url">https://www.imhr.de/en/</ref>
</desc>
<listRelation>
<relation active="#struct-303027" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-303027" type="direct">
<org type="institution" xml:id="struct-303027" status="VALID">
<orgName>Universität Regensburg</orgName>
<orgName type="acronym">UR</orgName>
<date type="start">2016-10-17</date>
<desc>
<address>
<addrLine>Universitätsstraße 31, 93053 Regensburg</addrLine>
<country key="DE"></country>
</address>
<ref type="url">http://www.uni-regensburg.de</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Allemagne</country>
</affiliation>
</author>
<author>
<name sortKey="Kerdpanich, Angkool" sort="Kerdpanich, Angkool" uniqKey="Kerdpanich A" first="Angkool" last="Kerdpanich">Angkool Kerdpanich</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-232783" status="INCOMING">
<orgName>Infectious Diseases Unit</orgName>
<desc>
<address>
<addrLine>Department of Pediatrics, 315 Ratchvidhi Rd. Thung Phyathai, Ratchthewi Bangkok 10400</addrLine>
<country key="TH"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-356459" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-356459" type="direct">
<org type="institution" xml:id="struct-356459" status="INCOMING">
<orgName>Phramongkutklao Hospital, Bangkok</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Thaïlande</country>
</affiliation>
</author>
<author>
<name sortKey="Montellano, May" sort="Montellano, May" uniqKey="Montellano M" first="May" last="Montellano">May Montellano</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-232784" status="INCOMING">
<orgName>Department of Pediatrics</orgName>
<desc>
<address>
<addrLine>667 Gastambide St.,Sampaloc, Manila</addrLine>
<country key="PH"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-356261" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-356261" type="direct">
<org type="institution" xml:id="struct-356261" status="INCOMING">
<orgName>Mary Chiles General Hospital</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Philippines</country>
</affiliation>
</author>
<author>
<name sortKey="Schwarz, Tino" sort="Schwarz, Tino" uniqKey="Schwarz T" first="Tino" last="Schwarz">Tino Schwarz</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-232785" status="INCOMING">
<orgName>Central Laboratory and Vaccination Centre</orgName>
<desc>
<address>
<addrLine>Klinikstrasse 1 - D 97070 Würzburg</addrLine>
<country key="DE"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-356262" type="direct"></relation>
<relation active="#struct-356460" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-356262" type="direct">
<org type="institution" xml:id="struct-356262" status="INCOMING">
<orgName>StiftungJuliusspital</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
<tutelle active="#struct-356460" type="direct">
<org type="institution" xml:id="struct-356460" status="INCOMING">
<orgName>StiftungJuliusspital Würzburg</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Allemagne</country>
</affiliation>
</author>
<author>
<name sortKey="Watanveerade, Veerachai" sort="Watanveerade, Veerachai" uniqKey="Watanveerade V" first="Veerachai" last="Watanveerade">Veerachai Watanveerade</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-232783" status="INCOMING">
<orgName>Infectious Diseases Unit</orgName>
<desc>
<address>
<addrLine>Department of Pediatrics, 315 Ratchvidhi Rd. Thung Phyathai, Ratchthewi Bangkok 10400</addrLine>
<country key="TH"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-356459" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-356459" type="direct">
<org type="institution" xml:id="struct-356459" status="INCOMING">
<orgName>Phramongkutklao Hospital, Bangkok</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Thaïlande</country>
</affiliation>
</author>
<author>
<name sortKey="Wenzel, Jurgen" sort="Wenzel, Jurgen" uniqKey="Wenzel J" first="Jürgen" last="Wenzel">Jürgen Wenzel</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-232782" status="VALID">
<orgName>Institute of Medical Microbiology and Hygiene</orgName>
<orgName type="acronym">IMHR</orgName>
<desc>
<address>
<addrLine>Universitätsstraße 31, 93053 Regensburg</addrLine>
<country key="DE"></country>
</address>
<ref type="url">https://www.imhr.de/en/</ref>
</desc>
<listRelation>
<relation active="#struct-303027" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-303027" type="direct">
<org type="institution" xml:id="struct-303027" status="VALID">
<orgName>Universität Regensburg</orgName>
<orgName type="acronym">UR</orgName>
<date type="start">2016-10-17</date>
<desc>
<address>
<addrLine>Universitätsstraße 31, 93053 Regensburg</addrLine>
<country key="DE"></country>
</address>
<ref type="url">http://www.uni-regensburg.de</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Allemagne</country>
</affiliation>
</author>
<author>
<name sortKey="Zalcman, Gerard" sort="Zalcman, Gerard" uniqKey="Zalcman G" first="Gerard" last="Zalcman">Gerard Zalcman</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-149166" status="VALID">
<orgName>Centre de recherche clinique [CHU Caen]</orgName>
<orgName type="acronym">CRC</orgName>
<desc>
<address>
<addrLine>Centre Hospitalier UniversitaireAvenue de la Côte de NacreCS 3000114033 CAEN cedex 9</addrLine>
<country key="FR"></country>
</address>
<ref type="url">https://www.chu-caen.fr/crcbn.html</ref>
</desc>
<listRelation>
<relation active="#struct-7127" type="direct"></relation>
<relation active="#struct-455934" type="indirect"></relation>
<relation active="#struct-300185" type="direct"></relation>
<relation active="#struct-575575" type="indirect"></relation>
<relation active="#struct-301261" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-7127" type="direct">
<org type="institution" xml:id="struct-7127" status="VALID">
<idno type="IdRef">026403064</idno>
<idno type="ISNI">0000000121864076</idno>
<orgName>Université de Caen Normandie</orgName>
<orgName type="acronym">UNICAEN</orgName>
<date type="start">1432-01-01</date>
<desc>
<address>
<addrLine>Esplanade de la Paix - CS 14032 - 14032 CAEN Cedex 5</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.unicaen.fr/</ref>
</desc>
<listRelation>
<relation active="#struct-455934" type="direct"></relation>
</listRelation>
</org>
</tutelle>
<tutelle active="#struct-455934" type="indirect">
<org type="regroupinstitution" xml:id="struct-455934" status="VALID">
<idno type="IdRef">190906332</idno>
<idno type="ISNI">0000000417859671 </idno>
<orgName>Normandie Université</orgName>
<orgName type="acronym">NU</orgName>
<date type="start">2015-01-01</date>
<desc>
<address>
<addrLine>Esplanade de la Paix - CS 14032 - 14032 Caen Cedex 5</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.normandie-univ.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle active="#struct-300185" type="direct">
<org type="institution" xml:id="struct-300185" status="VALID">
<idno type="IdRef">031245382</idno>
<orgName>CHU Caen</orgName>
<desc>
<address>
<addrLine>Avenue de la Côte de Nacre 14000 Caen</addrLine>
<country key="FR"></country>
</address>
<ref type="url">https://www.chu-caen.fr/</ref>
</desc>
<listRelation>
<relation active="#struct-455934" type="direct"></relation>
<relation active="#struct-575575" type="direct"></relation>
</listRelation>
</org>
</tutelle>
<tutelle active="#struct-575575" type="indirect">
<org type="regroupinstitution" xml:id="struct-575575" status="VALID">
<orgName>Tumorothèque de Caen Basse-Normandie</orgName>
<orgName type="acronym">TCBN</orgName>
<desc>
<address>
<addrLine>3 avenue du Général Harris14076 Caen cedex 5</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.tumorotheque-caen-basse-normandie.org/</ref>
</desc>
</org>
</tutelle>
<tutelle active="#struct-301261" type="direct">
<org type="institution" xml:id="struct-301261" status="VALID">
<idno type="ISNI">0000 0001 2106 7843 </idno>
<idno type="IdRef">031239218</idno>
<orgName>Centre Régional de Lutte contre le Cancer François Baclesse </orgName>
<orgName type="acronym">CRLC François Baclesse </orgName>
<desc>
<address>
<addrLine>3 avenue général Harris14000 Caen</addrLine>
<country key="FR"></country>
</address>
<ref type="url">https://www.baclesse.fr/</ref>
</desc>
<listRelation>
<relation active="#struct-455934" type="direct"></relation>
<relation active="#struct-575575" type="direct"></relation>
</listRelation>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author>
<name sortKey="Bambure, Vinod" sort="Bambure, Vinod" uniqKey="Bambure V" first="Vinod" last="Bambure">Vinod Bambure</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-232788" status="INCOMING">
<orgName>GlaxoSmithKline Vaccines [Bangalore]</orgName>
<desc>
<address>
<addrLine>Bangalore</addrLine>
<country key="IN"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-356461" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-356461" type="direct">
<org type="institution" xml:id="struct-356461" status="INCOMING">
<orgName>India GlaxoSmithKline Pharmaceuticals Ltd. (GSK Rx India)</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Inde</country>
</affiliation>
</author>
<author>
<name sortKey="Li, Ping" sort="Li, Ping" uniqKey="Li P" first="Ping" last="Li">Ping Li</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-232789" status="INCOMING">
<orgName>GlaxoSmithKline Vaccines [King of Prussia]</orgName>
<desc>
<address>
<addrLine>North America (NA) Head, Regulatory Affairs - Vaccines - King of Prussia, PA</addrLine>
<country key="US"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-356462" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-356462" type="direct">
<org type="institution" xml:id="struct-356462" status="VALID">
<orgName>GlaxoSmithKline [King of Prussia]</orgName>
<orgName type="acronym">GSK</orgName>
<desc>
<address>
<addrLine>King of Prussia, PA,</addrLine>
<country key="US"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>États-Unis</country>
</affiliation>
</author>
<author>
<name sortKey="Caplanusi, Adrian" sort="Caplanusi, Adrian" uniqKey="Caplanusi A" first="Adrian" last="Caplanusi">Adrian Caplanusi</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-232790" status="INCOMING">
<orgName>GlaxoSmithKline Vaccines [Wavre]</orgName>
<desc>
<address>
<addrLine>Parc de la Noire Epine Rue Fleming, 20 1300 - Wavre</addrLine>
<country key="BE"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-356463" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-356463" type="direct">
<org type="institution" xml:id="struct-356463" status="INCOMING">
<orgName>GlaxoSmithKline - Site de Wavre-Nord</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Belgique</country>
</affiliation>
</author>
<author>
<name sortKey="Madan, Anuradha" sort="Madan, Anuradha" uniqKey="Madan A" first="Anuradha" last="Madan">Anuradha Madan</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-232789" status="INCOMING">
<orgName>GlaxoSmithKline Vaccines [King of Prussia]</orgName>
<desc>
<address>
<addrLine>North America (NA) Head, Regulatory Affairs - Vaccines - King of Prussia, PA</addrLine>
<country key="US"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-356462" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-356462" type="direct">
<org type="institution" xml:id="struct-356462" status="VALID">
<orgName>GlaxoSmithKline [King of Prussia]</orgName>
<orgName type="acronym">GSK</orgName>
<desc>
<address>
<addrLine>King of Prussia, PA,</addrLine>
<country key="US"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>États-Unis</country>
</affiliation>
</author>
<author>
<name sortKey="Gillard, Paul" sort="Gillard, Paul" uniqKey="Gillard P" first="Paul" last="Gillard">Paul Gillard</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-232790" status="INCOMING">
<orgName>GlaxoSmithKline Vaccines [Wavre]</orgName>
<desc>
<address>
<addrLine>Parc de la Noire Epine Rue Fleming, 20 1300 - Wavre</addrLine>
<country key="BE"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-356463" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-356463" type="direct">
<org type="institution" xml:id="struct-356463" status="INCOMING">
<orgName>GlaxoSmithKline - Site de Wavre-Nord</orgName>
<desc>
<address>
<country key="FR"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Belgique</country>
</affiliation>
</author>
<author>
<name sortKey="Vaughn, David" sort="Vaughn, David" uniqKey="Vaughn D" first="David" last="Vaughn">David Vaughn</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-232789" status="INCOMING">
<orgName>GlaxoSmithKline Vaccines [King of Prussia]</orgName>
<desc>
<address>
<addrLine>North America (NA) Head, Regulatory Affairs - Vaccines - King of Prussia, PA</addrLine>
<country key="US"></country>
</address>
</desc>
<listRelation>
<relation active="#struct-356462" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle active="#struct-356462" type="direct">
<org type="institution" xml:id="struct-356462" status="VALID">
<orgName>GlaxoSmithKline [King of Prussia]</orgName>
<orgName type="acronym">GSK</orgName>
<desc>
<address>
<addrLine>King of Prussia, PA,</addrLine>
<country key="US"></country>
</address>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>États-Unis</country>
</affiliation>
</author>
</analytic>
<idno type="DOI">10.1186/1471-2334-13-435</idno>
<series>
<title level="j">BMC Infectious Diseases</title>
<idno type="ISSN">1471-2334</idno>
<imprint>
<date type="datePub">2013-09-16</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="mix" xml:lang="en">
<term>Adults</term>
<term>Antigen dose reduction</term>
<term>Children</term>
<term>H1N1</term>
<term>Immunogenicity</term>
<term>Influenza virus</term>
<term>Manufacturing capacity</term>
<term>Pandemic influenza vaccine</term>
<term>Persistence</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>BACKGROUND: Pandemicinfluenza vaccinemanufacturing capacity and distribution agility is enhanced through the availabilityof equivalent antigen-sparing vaccines. We evaluated equivalence in terms of immunogenicity between GlaxoSmithKline Vaccines' A/California/7/2009(H1N1)v-like-AS03 vaccines manufactured in Dresden (D-Pan), and Quebec (Q-Pan). METHODS: In two studies,334 adults 18-60 years of age received 2 doses of D-Pan or Q-Pan containing 3.75 mug haemagglutinin antigen (HA) adjuvanted with AS03Aadministered21 days apart, and 209 children 3-9 years of age received 1reduced dose of D-Panor Q-Pan (0.9 mug HA) or Q-Pan (1.9 mug HA) with AS03B. Haemagglutination inhibition (HI)titres were assessed before and 21 days post-vaccination. HI persistence was assessed after 12 months in adults and 6 months in children. RESULTS: Pre-defined criteria for immunological equivalence of Q-Pan versus D-Pan were achieved in both populations. After one vaccine dose, >=97.6% of adults and children had HI titres >=1:40, with increases in titre>=25.7-fold. CHMP and CBER regulatory acceptance criteria for influenza vaccines were exceeded by all groups in both studies at Day 21. In adults,the percentage with HI titres >=1:40 at Month 12 was 82.9% (Q-Pan) and 84.0% (D-Pan). In children, the percentages at Month 6 were 75.3.3% (Q-Pan0.9), 85.1% (D-Pan0.9) and 79.3% (Q-Pan1.9). Safety profile of the study vaccines was consistent with previously published data. CONCLUSION: Two studies indicate that A/California/7/2009 (H1N1)v-like HA manufactured at two sitesand combined with AS03 are equivalent in terms of immunogenicity in adults and children and highly immunogenic. Different HA doses elicited an adequate immune response through 180 days post-vaccination in children 3-9 years of age.Trial registrationClinicalTrials.gov: NCT00979407 and NCT01161160.</p>
</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Allemagne</li>
<li>Belgique</li>
<li>France</li>
<li>Inde</li>
<li>Philippines</li>
<li>Thaïlande</li>
<li>États-Unis</li>
</country>
</list>
<tree>
<country name="France">
<noRegion>
<name sortKey="Launay, Odile" sort="Launay, Odile" uniqKey="Launay O" first="Odile" last="Launay">Odile Launay</name>
</noRegion>
<name sortKey="Duval, Xavier" sort="Duval, Xavier" uniqKey="Duval X" first="Xavier" last="Duval">Xavier Duval</name>
<name sortKey="Fitoussi, Serge" sort="Fitoussi, Serge" uniqKey="Fitoussi S" first="Serge" last="Fitoussi">Serge Fitoussi</name>
<name sortKey="Zalcman, Gerard" sort="Zalcman, Gerard" uniqKey="Zalcman G" first="Gerard" last="Zalcman">Gerard Zalcman</name>
</country>
<country name="Allemagne">
<noRegion>
<name sortKey="Jilg, Wolfgang" sort="Jilg, Wolfgang" uniqKey="Jilg W" first="Wolfgang" last="Jilg">Wolfgang Jilg</name>
</noRegion>
<name sortKey="Schwarz, Tino" sort="Schwarz, Tino" uniqKey="Schwarz T" first="Tino" last="Schwarz">Tino Schwarz</name>
<name sortKey="Wenzel, Jurgen" sort="Wenzel, Jurgen" uniqKey="Wenzel J" first="Jürgen" last="Wenzel">Jürgen Wenzel</name>
</country>
<country name="Thaïlande">
<noRegion>
<name sortKey="Kerdpanich, Angkool" sort="Kerdpanich, Angkool" uniqKey="Kerdpanich A" first="Angkool" last="Kerdpanich">Angkool Kerdpanich</name>
</noRegion>
<name sortKey="Watanveerade, Veerachai" sort="Watanveerade, Veerachai" uniqKey="Watanveerade V" first="Veerachai" last="Watanveerade">Veerachai Watanveerade</name>
</country>
<country name="Philippines">
<noRegion>
<name sortKey="Montellano, May" sort="Montellano, May" uniqKey="Montellano M" first="May" last="Montellano">May Montellano</name>
</noRegion>
</country>
<country name="Inde">
<noRegion>
<name sortKey="Bambure, Vinod" sort="Bambure, Vinod" uniqKey="Bambure V" first="Vinod" last="Bambure">Vinod Bambure</name>
</noRegion>
</country>
<country name="États-Unis">
<noRegion>
<name sortKey="Li, Ping" sort="Li, Ping" uniqKey="Li P" first="Ping" last="Li">Ping Li</name>
</noRegion>
<name sortKey="Madan, Anuradha" sort="Madan, Anuradha" uniqKey="Madan A" first="Anuradha" last="Madan">Anuradha Madan</name>
<name sortKey="Vaughn, David" sort="Vaughn, David" uniqKey="Vaughn D" first="David" last="Vaughn">David Vaughn</name>
</country>
<country name="Belgique">
<noRegion>
<name sortKey="Caplanusi, Adrian" sort="Caplanusi, Adrian" uniqKey="Caplanusi A" first="Adrian" last="Caplanusi">Adrian Caplanusi</name>
</noRegion>
<name sortKey="Gillard, Paul" sort="Gillard, Paul" uniqKey="Gillard P" first="Paul" last="Gillard">Paul Gillard</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000780 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000780 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     Hal:inserm-00868824
   |texte=   Extended antigen sparing potential of AS03-adjuvanted pandemic H1N1 vaccines in children, and immunological equivalence of two formulations of AS03-adjuvanted H1N1 vaccines: results from two randomised trials.
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021